SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001370053-19-000019
Filing Date
2019-05-07
Accepted
2019-05-07 16:22:45
Documents
63
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q anab-33119x10q.htm 10-Q 911536
2 EXHIBIT 31.1 anab-33119x10qxexx311.htm EX-31.1 8644
3 EXHIBIT 31.2 anab-33119x10qxexx312.htm EX-31.2 8627
4 EXHIBIT 32.1 anab-33119x10qxexx321.htm EX-32.1 5778
5 EXHIBIT 32.2 anab-33119x10qxexx322.htm EX-32.2 5749
12 pipelinechartfinala01.jpg GRAPHIC 88328
  Complete submission text file 0001370053-19-000019.txt   4575675

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT anab-20190331.xml EX-101.INS 809026
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anab-20190331.xsd EX-101.SCH 41480
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anab-20190331_cal.xml EX-101.CAL 66396
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anab-20190331_def.xml EX-101.DEF 154851
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anab-20190331_lab.xml EX-101.LAB 527521
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anab-20190331_pre.xml EX-101.PRE 285608
Mailing Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO INC (Filer) CIK: 0001370053 (see all company filings)

IRS No.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37985 | Film No.: 19803439
SIC: 2834 Pharmaceutical Preparations